✦ LIBER ✦

Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes

✍ Scribed by Takanori Ishida; Takayoshi Kiba; Motohiro Takeda; Kotone Matsuyama; Satoshi Teramukai; Ryota Ishiwata; Norikazu Masuda; Yuichi Takatsuka; Shinzaburo Noguchi; Chikashi Ishioka; Masanori Fukushima; Noriaki Ohuchi

Publisher: Springer
Year: 2008
Tongue: English
Weight: 367 KB
Volume: 64
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0882-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of oral vinorelbine in co

Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes

✍ Alison Jones; Mary O’Brien; Harald Sommer; Elzbieta Nowara; Anja Welt; Tadeusz P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 364 KB

A phase II study of trastuzumab and cape

A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial

✍ Daigo Yamamoto; Satoru Iwase; Kaoru Kitamura; Hiroki Odagiri; Chizuko Yamamoto; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 232 KB

An all-oral combination of metronomic cy

An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study

✍ Zhonghua Wang; Jingsong Lu; Shiangjiin Leaw; Xiaonan Hong; Jialei Wang; Zhimin S 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 223 KB

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

Vinorelbine and fluorouracil plus leucov

Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study

✍ Cristiano Oliva; Paola Bergnolo; Manuela Inguì; Lavinia Bianco; Paolo Pochettino 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 195 KB

Phase I trial of oral mTOR inhibitor eve

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer

✍ Guy Jerusalem; Angelica Fasolo; Veronique Dieras; Fatima Cardoso; Jonas Bergh; L 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 326 KB